Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women

Journal of Midwifery and Women's Health

Volumn 62, Issue 3, 2017, Pages 253-269

  Baraona, L Kim ^a   Lovelace, Dawn ^a,b   Daniels, Julie L ^a   McDaniel, Linda ^a  

^a Frontier Nursing University   (United States)

^b Coulee Medical Center ^*  (United States)

Author keywords

breastfeeding; bupropion; clonidine; electronic nicotine delivery systems; nicotine; nicotine replacement therapy (NRT); nortriptyline; pregnancy; smoking; smoking cessation; tobacco cessation; varenicline

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NORTRIPTYLINE; VARENICLINE; NICOTINE GUM;

ACUPUNCTURE; ADVERSE OUTCOME; BEHAVIOR THERAPY; BREAST FEEDING; DRUG EFFICACY; DRUG SAFETY; ELECTRONIC CIGARETTE; EPIGENETICS; EVIDENCE BASED MEDICINE; HEALTH HAZARD; HUMAN; HYPNOSIS; KINESIOTHERAPY; MATERNAL SMOKING; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PATIENT COUNSELING; PHARMACOKINETICS; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK BENEFIT ANALYSIS; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; UNITED STATES; CHEMISTRY; COMPLICATION; DRUG EFFECTS; FEMALE; FETUS; LACTATION; PREGNANCY; PROCEDURES; SMOKING; TOBACCO;

BUPROPION; FEMALE; FETUS; HUMANS; LACTATION; NICOTINE; PREGNANCY; PREGNANT WOMEN; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO USE CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; VARENICLINE;

EID: 85021079142     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/jmwh.12616     Document Type: Review

References (72)

1. World Health Organization. Tobacco fact sheet. http://www.who.int/mediacentre/factsheets/fs339/en/. Updated June, 2016. Accessed August 10. 2016.
2. Hu SS, Heff L, Agatu, IT, et al. Tobacco product use among adults—United States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65:685-691.
3. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: USDHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.
4. Centers for Disease Control and Prevention. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking Attributable Disease. Atlanta, GA: Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US); 2010.
5. Goszczynska E, Knol-Michalowska K, Petrykoska A. How do pregnant women justify smoking? A qualitative study with implications for nurses’ and midwives’ anti-tobacco interventions. J Adv Nurs. 2016;72(7):1567-1578.
6. Ebert L, Fahy K. Why do women continue to smoke in pregnancy? Women Birth. 2007;20(4):161-168.
7. Fiore M, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf. Accessed September 11, 2016.
8. Tanner JA, Chenowith MJ, Tyndale RF. Pharmacogenetics of nicotine and associated smoking behaviors. Curr Top Behav Neurosci. 2015;23:37-86.
9. England LJ, Bunell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med. 2015;49(2):286-293.
10. Bergen AW, Michel M, Nishita D, et al. Drug metabolizing enzyme and transporter gene variation, nicotine metabolism, prospective abstinence, and cigarette consumption. PloS One. 2015;10(7):e0126113.
11. Baurley JW, Edlund CK, Pardamean CI, et al. Genome-wide association of the laboratory-based nicotine metabolite ratio in three ancestries. Nicotine Tob Res. 2016;18(9):1837-1844.
12. Dubroff JG, Doot RK, Falcone M,et al. Decreased nicotinic receptor availability in smokers with slow rates of nicotine metabolism. J Nucl Med. 2015;56(11):1724-1729.
13. Chen LS, Bloom AJ, Baker TB, et al. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene CYP2A6. Addiction. 2014;109(1):128-137.
14. Hughes JR. Effects of abstinence from tobacco—valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315-327.
15. Rahmanian, SD, Diaz PT, Wewers ME. Tobacco use and cessation among women: research and treatment-related issues. J Womens Health. 2011;20(3):349-357.
16. Varescon I, Leignel S, Gerard C, Aubourg F, Detilleux M. Self-esteem, psychological distress and coping styles in pregnant smokers and non-smokers. Psychol Rep. 2013;113(3): 935-947.
17. Pang RD, Zvolensky MJ, Schmidt NB, Leventhal AM. Gender differences in negative reinforcement smoking expectancies. Nicotine and Tob Res. 2015;17(6):750-754.
18. Dietz PM, Homa D, England LJ, et al. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am. J. Epidemiol. 2011;173(3);355-359.
19. Albrecht S, Maloni J, Thomas K, Jones R, Halleran J, Osborne J. Smoking cessation counseling for pregnant women who smoke: scientific basis for practice for AWONN's SUCCESS project. J Obstet Gynecol Neonatal Nurs. 2004;33(3):298-305.
20. Knopik VS, Maccani MA, Francazio S, McGeary JE. The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol. 2012;24(4): 1277-1390.
21. Einarson, A., Riordan, S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009;65(4):325-330.
22. Sbrana E, Suter MA, Abramovici AR, et al. Maternal tobacco use is associated with increased markers of oxidative stress in the placenta. Am J Obstet Gynecol. 2011;205(3):246.e1-246.e7.
23. Maritz G, Harding R. Smoking and nicotine before and soon after birth: evidence for altered lung development. Int J Environ Res Public Health. 2011;8:875-898.
24. Clifford A, Lan L, Chen R. Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: a literature review. Neurotoxicol Teratol. 2012;34(6): 560-570.
25. Patnode C, Henderson J, Thompson J, Senger C, Formann S, Whitlock E. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Task Force. Ann Intern Med. 2015;164:608-621.
26. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomized, placebo-controlled clinical trial. The Lancet. 2016;387:2507-2520.
27. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; Issue 5.Art.No.:CD009329. https://doi.org/10.1002/14651858.CD009329.pub2.
28. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014;(1):CD000031. https://doi.org/10.1002/14651858.CD000031.pub4.
29. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016; Issue 5.Art. No.:CD006103. https://doi.org/10.1002/14651858.CD006103.pub7.
30. Koegelenberg CNF, Noor F, Bateman ED, et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA. 2014;312(2):155-161.
31. Department of Health and Human Services Food and Drug Administration. http://www.fda.gov/default.htm. Accessed December 19, 2016.
32. Nicotine. In: Lexicomp, Lexi-Drugs [database online]. St. Louis, MO: Wolters Kluwer Health, Inc. http://online.lexi.com. Updated May 5, 2016. Accessed August 16, 2016.
33. Clonidine. In: LactMed [database online]. Bethesda, MD: National Library of Medicine (US). https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Updated March 10, 2015. Accessed September 11, 2016.
34. Nortriptyline. In: LactMed [database online]. Bethesda, MD: National Library of Medicine (US). https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Updated September 1, 2016. Accessed September 11, 2016.
35. Bupropion hydrochloride. In: Lexicomp, Lexi-Drugs [database online]. St. Louis, MO: Wolters Kluwer Health, Inc. http://online.lexi.com. Updated April 20, 2016. Accessed September 5, 2016.
36. Varenicline. In: Lexicomp, Lexi-Drugs [database online]. St. Louis, MO: Wolters Kluwer Health, Inc. http://online.lexi.com. Updated 2007. Accessed September 5, 2016; 35.
37. Bupropion. In: LactMed [database online]. Bethesda, MD: National Library of Medicine (US). https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Updated November 6, 2015. Accessed September 11, 2016.
38. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2009;(3):CD001055. https://doi.org/10.1002/14651858.CD001055.pub3
39. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;(12):CD010078. https://doi.org/10.1002/14651858.
40. Vas LR, Coleman T, Cooper S, Aveyard P, Leonardi-Bee J. The nicotine metabolite ratio in pregnancy measured by trans-3′-hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine and Tob Res. 2015;17(11):1318-1323.
41. Chamberlain C, Mara-Eves A, Olvier S, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy (Review) Cochrane Database Syst Rev. 2013; Issue 10, Art No.: CD001055. https://doi.org/10.1002/14651858.CD001055.pub4.
42. Ebert L, Van der Riet P, Fahy K. What do midwives need to understand/know about smoking in pregnancy? Women Birth. 2009;22(1):35-40. https://doi.org/10.1016/j.wombi.2008.11.001.
43. Jaddoe V, Troe E, Hofman A, et al. Active and passive maternal smoking during pregnancy and the risks of low birthweight and preterm birth: the generation R study. Paediatr Perinat Epidemiol. 2008;22:162-171. https://doi.org/10.1111/j.1365-3016.2007.00916.x.
44. Oncken CA, Dornelas E, Greene J, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol. 2008;112:859-867.
45. Oncken C, Campbell W, Chan G, Hatsukami D, Kranzler HR. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. J Matern Fetal Neonatal Med. 2009;22:751-758. https://doi.org/10.1080/14767050902004515.
46. Oncken, C, Hardardottir H, Hatsukami DK, Lupo VR, Rodis JF, Smeltzer JS. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol. 1997;90:569-574.
47. Myung et al. Efficacy and safety of pharmacotherapy for smokers: a meta-analysis. BJOG. 2012;119:1029-1039.
48. Berard A, Zhao J, Sheehy O. Success of smoking cessation interventions during pregnancy. Am J Obstet Gynecol. 2016;215(5):611.e1-1611.e1. https://doi.org/10.1016/j.ajog.2016.06.059.
49. Cooper S, Lewis S, Thornton, J, et al. The SNAP trial: a randomized placebo-controlled trial of nicotine replacement therapy in pregnancy-clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technol Assess. 2014;18(54). https://doi.org/10.3310/hta18540.
50. Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med. 2012;366(9):808-818.
51. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf. 2001;24(4):277-322.
52. Oncken CA, Kranzler HR. What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? Nicotine Tob Res. 2009;11(11):1265-1273.
53. Fokina VM, West H, Oncken C, et al. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Am J Obstet Gynecol. 2016;215(4):497.e1-7. https://doi.org/10.1016/j.ajog.2016.05.016
54. Fokina VM, Xu M, Rytting E, et al. Pharmacokinetics of bupropion and its pharmacologically active metabolites in pregnancy. Drug Metab Dispos. 2016;44(11):1832-1838. https://doi.org/10.1124/dmd.116.071530.
55. Bupropion Pregnancy Registry, Final Report. GlaxoSmitheKline; 2008:1-24. http://pregnancyregistry.gsk.com/bupropion.html Issued August 2008. Accessed September 5, 2016.
56. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 2005;192(3):932-936.
57. Cole JA, Modell JG, Haight BR, et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16(5):474-484.
58. Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry. 2009;54(4):242-246.
59. Louik C, Kerr S, Mitchell AA. First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiol Drug Saf. 2014;23(10):1066-1075.
60. Cressman AM, Pupco A, Kim E, Koren G, Bozzo P. Smoking cessation therapy during pregnancy—motherrisk update. Can Fam Physician. 2012;58:525-527.
61. Varenicline pregnancy cohort study. Clinical Trials.gov. http://clinicaltrials.gov/ct2/show/NCT01290445. January 25, 2011. June 30, 2016. Accessed September 5, 2016.
62. Sachs HC, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132(3):e796-e809. https://doi.org/10.1542/peds.2013-1985.
63. Ilett K, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther. 2003;74(6):516-524.
64. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016; Issue 9.Art. No.: CD010216. https://doi.org/10.1002/14651858.CD010216.pub3.
65. American Academy of Pediatrics Section on Tobacco Control. Policy statement: electronic nicotine delivery systems. Pediatrics. 2015;136(5):1018-1026.
66. Smoking cessation. In: Natural Medicines [database online]. Natural Medicines Corporation. https://naturalmedicines-therapeuticresearch-com.frontier.idm.oclc.org/databases/medical-conditions/s/smoking-cessation.aspx Updated 2016. Accessed September 5, 2016.
67. Barnes J, Dong CY, McRobbie H, Walker N, Mehta M, Stead LF. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2010; Issue 10. Art. No.: CD001008. https://doi.org/10.1002/14651858.CD001008.pub2.
68. Ussher MH, Taylor AH, Faulkner GEJ. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2014;(8): CD002295. https://doi.org/10.1002/14651858.CD002295.pub5.
69. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2014; Issue 1. Art. No.: CD000009. https://doi.org/10.1002/14651858.CD000009.pub4.
70. Stead LF, Lancaster T. Group behaviour therapy programs for smoking cessation. Cochrane Database Syst Rev. 2005; Issue 2. Art. No.: CD001007. https://doi.org/10.1002/14651858.CD001007.pub2.
71. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016;(4): CD006611. https://doi.org/10.1002/14651858.CD006611.pub4.
72. Miller WR, Rollnick S. What is motivational interviewing. In: Motivational Interviewing: Helping People Change. 2nd ed. New York, NY: Guilford Press. 2002:34-41.